Stifel Nicolaus analyst Shlomo Rosenbaum maintained a Buy rating on Equifax (EFX – Research Report) today and set a price target of ...

Jefferies analyst Surinder Thind has reiterated their bullish stance on EFX stock, giving a Buy rating today. Surinder Thind has given his Buy ...

Equifax, one of the biggest credit reporting companies in the U.S., had a huge data breach that affected around 147 million ...

EFX's 3Q24 results showed strong revenue growth, driven by a significant increase in mortgage solutions and expanding ...

UBS has recently initiated Equifax Inc (EFX) stock to Buy rating, as announced on October 1, 2024, according to Finviz. Earlier, on September 19, 2024, Exane BNP Paribas had raised the stock from a ...

On Thursday, Equifax Inc (EFX) stock saw a decline, ending the day at $280.3 which represents a decrease of $-9.66 or -3.33% from the prior close of $289.96. The stock opened at $278 and touched a low ...

Q3 2024 Earnings Call Transcript October 17, 2024 Operator: Greetings, and welcome to the Equifax Inc. Third Quarter 2024 ...

In the last three months, 9 analysts have published ratings on Equifax EFX, offering a diverse range of perspectives from ...

Equifax Inc. EFX reported mixed third-quarter 2024 results, wherein earnings surpassed the Zacks Consensus Estimate while ...

Equifax (EFX) stock slid 3.8% in Wednesday after-hours trading after the credit analytics and data technology company issued soft Q4 guidance after mixed Q3 results.

Akero Therapeutics (NASDAQ:AKRO) is a biotechnology company that is developing a treatment for Metabolic ...

Sporting a Zacks Rank #2 (Buy), here are three top-rated stocks that investors will want to consider as their Q3 results ...